New INVENIO™ Fourier Transform Infrared research spectrometer launched by Bruker

Bruker today announces the launch of the new INVENIO™ Fourier Transform Infrared (FT-IR) research spectrometer. The INVENIO is the successor to the renowned VERTEX 70 FT-IR for advanced R&D applications.

The novel INVENIO combines many innovations with proven Vertex 70 technologies, such as unique FM technology for simultaneous mid and far IR spectroscopy. The new MultiTectTM technology allows for control of up to five internal detectors, covering the spectral range from far infrared to Vis/UV. A DigiTectTM detector slot enables additional flexibility for even more detectors. The smart INVENIO beam path further improves optical throughput and spectroscopic sensitivity.

In addition to performance and flexibility, a major goal of the INVENIO is to simplify the research user's experience. An integrated touch panel enables intuitive configuration set-ups and workflows for R&D applications, and the system can also be switched to notebook operation. The TransitTM channel allows for easy transmission measurements, without removing experiments from the sample compartment.

The INVENIO is an intelligent spectrometer with many exciting features that set it apart from other research FT-IRs. These include electronically coded beam windows with magnetic mount, an automated internal attenuator wheel and an 8-position validation wheel for standards and customer-specific filters. The unique Bruker RocksolidTM interferometer and FM technology for simultaneous mid and far IR complete the INVENIO feature set.

Source:

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration